KELGARTA
LIVE

Serial Number

79294992

Owner

NOVARTIS AG

Filing Date

Aug 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KELGARTA Trademark

Serial Number: 79294992 • Registration: 6268984

KELGARTA is a trademark filed by NOVARTIS AG on August 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

August 21, 2020

Registration Date

February 16, 2021

Published for Opposition

December 1, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 16, 2026 REM3
INTERNATIONAL REGISTRATION RENEWED
Jan 31, 2024 RNWL
CHANGE OF OWNER RECEIVED FROM IB
Jan 22, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Apr 11, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 20, 2021 FICS
FINAL DISPOSITION PROCESSED
Mar 20, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Mar 18, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Feb 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 11, 2020 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 2, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2020 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2020 CNSA
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 13, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 8, 2020 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 1, 2020 SDRC